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Chitinase-3-like-1 protein (CHI3L1) also called YKL-40, is a 40 kDa mammalian 
glycoprotein which is a heparin, chitin and collagen binding member of the mamma-
lian chitinase-like proteins. Biological activities of CHI3L1 embrace regulation of cell 
proliferation, adhesion, angiogenesis, migration and activation. CHI3L1 is produced 
by variety of cells, including neutrophils, monocytes/macrophages, osteoclasts and 
Kupffer cells [1]. CHI3L1 secretion is induced by interferon (INF)-g and interleukin 
(IL)-6 and is an acute phase reactant associated with disease severity and mortality in 
a variety of infectious [2]. In this study, we have examined the expression and locali-
zation of CHI3L1 during the differentiation and maturation of monocyte derived 
dendritic cells by real time RT-PCR, Western Blot, Confocal Immunofluorescence, and 
Immunocytochemical assays. Potential nuclear localization signal (NLS) was determi-
nated using the open source software cNLS Mapper and Chimera. Peripheral blood 
monocytes were differentiated toward immature DCs (iDC) and mature DCs (mDCs) 
through a combination of factors and cytokines. Our result showed, for the first time, 
that CHI3L1 is expressed during the process of differentiation and maturation of DCs 
in time dependent manner. Furthermore, CHI3L1 is evenly distributed in cytoplasm 
and in the nucleus of both the iDCs and mDCs. 
In conclusion, the discovery of CHI3L1 expression in DCs has opened new dilem-
ma for designing DC-based cancer immunotherapeutic. In fact, on the light of these 
results one can’t exclude that as well as activated Tumor-associated macrophages 
(TAMs) also DCs infiltration could to be a significant unfavorable prognostic factor 
for cancer patients.
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